MINNEAPOLIS, Aug. 6 /PRNewswire-FirstCall/ -- ATS Medical announced today that it will deliver a presentation at the 27th Annual Canaccord Adams Global Growth Conference in Boston. Michael Dale, President and Chief Executive Officer, is scheduled to present to leading institutional investment representatives on Thursday, August 9, 2007, at the InterContinental Boston.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)

    Mr. Dale will join executives from nearly 270 public and private companies for the conference, one of the longest-running institutional events focused exclusively on growth companies.

    "ATS Medical has made great strides towards creating an organization with broader diversification and much greater potential. With a more robust product line now in place, we are well positioned to take the next step towards our intermediate goal of becoming the leading innovator and provider of proprietary technologies and services to the cardiac surgery community with annual revenues in excess of $100 million. We look forward to sharing our progress and potential with some of the country's top growth investors at this year's Growth Conference," said Mr. Dale. "This is an ideal venue in which we can provide an important mid-year update of our growth strategy and achievements."

    "Long known as the Summer Seminar, this year we have changed the name of the event to better reflect the expanding international scope of companies and investors attending," said Kevin Dunn, President and CEO of Canaccord Adams Inc. "It is our continued mission to deliver a top quality event for institutional clients and venture capitalists, connecting them with exciting growth companies. The conference will also afford corporate clients access to investing insights and valuable market information. Our goal is to provide a premier forum for sharing knowledge, discussing emerging trends and identifying investment opportunities for public and private companies, venture capitalists and institutional investors."

    The Canaccord Adams Global Growth Conference is one of the oldest and largest programs showcasing both publicly traded and privately held growth companies. Many of the presenting public companies are covered by Canaccord Adams' global team of equity analysts. To learn more about the conference, please contact Nadine Miller at 617.371.3842 or Nadine.Miller@CanaccordAdams.com.

    About ATS Medical

    ATS Medical, Inc. provides innovative products and services focused on cardiac surgery. The company, global in scope, has been headquartered in Minneapolis, Minnesota. More than 135,000 ATS Open Pivot? Heart Valves, which utilize a unique pivot design resulting in exceptional performance and low risk profile, have been implanted in patients worldwide. The ATS 3F? brand encompasses multiple tissue heart valve product offerings at varying steps from market introductions to clinical trials to development projects that incorporate less invasive valve replacement technology. ATS Medical's focus on serving the cardiac surgery community is further strengthened by offerings that include ATS Simulus(TM) annuloplasty products for heart valve repair, SurgiFrost? and FrostByte? products for surgical cryoablation of cardiac arrhythmias, and RTI-Cardiovascular for allograft tissue services. The ATS Medical web site is http://www.atsmedical.com.

    About Canaccord Adams

    Canaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients a unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, our 225 professionals seek out emerging opportunities in our key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate, and Industrial Growth. Located in ten offices internationally, our experienced team generates focused, actionable ideas that identify opportunity and facilitate growth. Canaccord Adams, the international capital markets division of Canaccord Capital Inc., has operations in Toronto, London, Boston, Vancouver, New York, Calgary, Montreal, San Francisco, Houston and Chicago. More information is available at http://www.canaccordadams.com.

    Canaccord Adams Inc., Member NASD/SIPC.

    Canaccord Adams Limited is regulated and authorized by the Financial Services Authority and is a member of the LSE.

    Canaccord Adams is a division of Canaccord Capital Corporation, Member IDA/CIPF.

    About Canaccord Capital, Inc.

    Through its principal subsidiaries, Canaccord Capital Inc. (TSX & AIM: CCI) is a leading independent full-service investment dealer in Canada, with capital markets operations in the United Kingdom and the United States of America. Canaccord is publicly traded on both the Toronto Stock Exchange and AIM, a market operated by the London Stock Exchange. Canaccord has operations in two of the principal segments of the securities industry: private client services and capital markets. Together these operations offer a wide range of complementary investment products, brokerage services and investment banking services to Canaccord's private, institutional and corporate clients. Canaccord has approximately 1,570 employees worldwide in 31 offices, including 23 Private Client Services offices located across Canada. Canaccord Adams, the international capital markets division, has operations in Toronto, London, Boston, Vancouver, New York, Calgary, Montreal, San Francisco, Houston and Chicago.

    Source: ATS Medical, Inc.